Related Experiment Video
Updated: Apr 12, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet inhibition with ticagrelor for left ventricular assist device thrombosis
Guilherme H Oliveira1, Sadeer G Al-Kindi2, Chantal ElAmm2
1From the Department of Medicine (G.H.O., S.G.A., C.E., M.Y.Q., R.D.B., M.N.O., M.G., D.I.S.) and Department of Surgery (S.D., B.M., S.J.P.), Advanced Heart Failure and Transplant Center, Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH. guilherme.oliveira@uhhospitals.org.
No abstract available in PubMed .
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

